JG
John Gustofson
President, Head of Ventures at Chugai Venture Fund
Ashland, Massachusetts
Overview
John Gustofson is the President and Head of Chugai Ventures Fund, with a strong background in start-up ventures and venture capital. He has successfully invested in companies like Esha Research and Caraway Therapeutics, showcasing his expertise in the pharmaceutical and biotech sectors.
With a career spanning roles at AbbVie, AstraZeneca, and Altus Pharmaceuticals, Gustofson has demonstrated leadership in business development and clinical development, making strategic contributions to the biopharmaceutical industry.
Work Experience
President, Head of Ventures
2023 - Current
Chugai Ventures, LLC invests in emerging areas of science in digital technology, platform technologies and therapeutics aligned with Chugai's R&D. This fund will deploy$200M and will look to invest in the US, EU and Japan.
Managing Director, AbbVie Ventures
2016 - 2023
Sr. Director, Ventures & Early Stage Collaborations
2013 - 2016
AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.
Raised $15,000,249,999.00.
Business Development Director
2009 - 2013
Director, Business Development
2005 - 2009
Director, Business and Market Development
2003 - 2005
Principal Consultant
2000 - 2002
Pharmaceutical and Biotechnolyg focused strategy consulting
Consultant
1999 - 2000
Business and Product Development Manager
1997 - 1998
Scientist
1993 - 1995